{
  "ticker": "OMER",
  "company_name": "Omeros Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00599664",
      "title": "Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Urinary Calculi, Urinary Stones, Urinary Tract Stones",
      "start_date": "2007-12",
      "completion_date": "2008-09",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT01579565",
      "title": "Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Intraocular Lens Replacement",
      "start_date": "2012-04",
      "completion_date": "2013-01",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT05889299",
      "title": "Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria",
      "status": "UNKNOWN",
      "phase": "PHASE1",
      "condition": "Paroxysmal Nocturnal Hemoglobinuria",
      "start_date": "2022-12-09",
      "completion_date": "2024-06-30",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT00226772",
      "title": "Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Knee Injuries",
      "start_date": "2005-06",
      "completion_date": "2011-03",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT06298955",
      "title": "Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Paroxysmal Nocturnal Hemoglobinuria",
      "start_date": "2024-02-19",
      "completion_date": "2027-04",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT02132312",
      "title": "A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Unilateral Cataract Extraction, Congenital Cataract",
      "start_date": "2014-07",
      "completion_date": "2016-09-12",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT02682407",
      "title": "Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721",
      "status": "UNKNOWN",
      "phase": "PHASE2",
      "condition": "IgAN, Lupus Nephritis, MN, C3 Glomerulopathy",
      "start_date": "2016-02",
      "completion_date": "2020-12",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT04829799",
      "title": "Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain",
      "status": "WITHDRAWN",
      "phase": "PHASE4",
      "condition": "Pain Reduction",
      "start_date": "2022-02",
      "completion_date": "2023-08",
      "enrollment": 0,
      "sponsor": "University of Florida"
    },
    {
      "nct_id": "NCT05972967",
      "title": "Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Paroxysmal Nocturnal Hemoglobinuria",
      "start_date": "2023-03-27",
      "completion_date": "2024-10-10",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    },
    {
      "nct_id": "NCT05855083",
      "title": "Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation",
      "start_date": "2023-05-01",
      "completion_date": "2025-12",
      "enrollment": 0,
      "sponsor": "Omeros Corporation"
    }
  ],
  "summary": {
    "total_trials": 29,
    "by_phase": {
      "PHASE1": 2,
      "PHASE3": 10,
      "PHASE2": 10,
      "PHASE4": 2,
      "PHASE1, PHASE2": 3,
      "": 1,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 17,
      "UNKNOWN": 2,
      "RECRUITING": 3,
      "WITHDRAWN": 1,
      "TERMINATED": 5,
      "AVAILABLE": 1
    },
    "active_trials": 3,
    "completed_trials": 17,
    "conditions": [
      "Anterior Cruciate Ligament Reconstruction",
      "C3 Glomerulopathy, Idiopathic Immune Complex-Mediated Glomerulonephritis",
      "Cataract",
      "Cataract Extraction",
      "Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)",
      "Heroin Dependence, Nicotine Dependence",
      "Huntington's Disease",
      "IgA Nephropathy",
      "IgAN, Lupus Nephritis, MN, C3 Glomerulopathy",
      "Intraocular Lens Replacement",
      "Intraocular Lens Replacement, Intraoperative Floppy Iris Syndrome",
      "Knee Injuries",
      "Meniscal Tear",
      "Opioid Abuse",
      "Pain Reduction",
      "Paroxysmal Nocturnal Hemoglobinuria",
      "Postoperative Pain",
      "Schizophrenia",
      "Thrombotic Microangiopathies",
      "Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome",
      "Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation",
      "Unilateral Cataract Extraction, Congenital Cataract",
      "Urinary Calculi, Urinary Stones, Urinary Tract Stones",
      "Urinary Calculi, Urinary Stones, Urinary Tract Stones, Renal Calculi, Kidney Stones"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:37.369933",
    "search_query": "Omeros Corporation",
    "url": "https://clinicaltrials.gov/search?term=Omeros+Corporation"
  }
}